75 related articles for article (PubMed ID: 9101449)
1. The significance of tumor necrosis factor (TNF) levels for rejection of joint allograft.
Watanabe H; Nagasawa K; Hamada Y; Toshima T; Sakano Y; Akamatsu N
J Reconstr Microsurg; 1997 Apr; 13(3):193-7. PubMed ID: 9101449
[TBL] [Abstract][Full Text] [Related]
2. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
3. Histological characteristics of acute rejection in vascularized allografts of bone.
Gotfried Y; Yaremchuk MJ; Randolph MA; Weiland AJ
J Bone Joint Surg Am; 1987 Mar; 69(3):410-25. PubMed ID: 3493245
[TBL] [Abstract][Full Text] [Related]
4. Limb allografts in rats immunosuppressed with cyclosporine: as a whole-joint allograft.
Hotokebuchi T; Arai K; Takagishi K; Arita C; Sugioka Y; Kaibara N
Plast Reconstr Surg; 1989 Jun; 83(6):1027-36; discussion 1037-8. PubMed ID: 2786223
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic vascularized osteochondral allografts in an immunosuppressed rat model.
Shigetomi M; Hickey MJ; Hurley JV; Riccio M; Niazi ZB; Ohta I
J Reconstr Microsurg; 1996 Feb; 12(2):113-9. PubMed ID: 8656399
[TBL] [Abstract][Full Text] [Related]
6. Effect of a new immunosuppressant, FTY720, on joint allografts.
Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y
J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553
[TBL] [Abstract][Full Text] [Related]
7. [Experimental studies on vascularized allogeneic joint transplantation in rats].
Muramatsu K
Nihon Seikeigeka Gakkai Zasshi; 1992 Apr; 66(4):315-25. PubMed ID: 1593202
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive effect of the hydrophobic extract of a Chinese herb on rat lung allograft rejection.
Yap HK; Zuo XJ; Toyoda M; Okada Y; Ang SG; Lai YH; Matloff JM; Marchevsky A; Ramgolam VS; Jordan SC
Transplant Proc; 1998 Jun; 30(4):980-1. PubMed ID: 9636395
[No Abstract] [Full Text] [Related]
9. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
Bathgate AJ; Lee P; Hayes PC; Simpson KJ
Liver Transpl; 2000 Nov; 6(6):721-7. PubMed ID: 11084058
[TBL] [Abstract][Full Text] [Related]
10. The bimodal expression of tumor necrosis factor-alpha in association with rat lung reimplantation and allograft rejection.
DeMeester SR; Rolfe MW; Kunkel SL; Swiderski DL; Lincoln PM; Deeb GM; Strieter RM
J Immunol; 1993 Mar; 150(6):2494-505. PubMed ID: 8450226
[TBL] [Abstract][Full Text] [Related]
11. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
Schmid C; Heemann U; Azuma H; Tilney NL
Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
[No Abstract] [Full Text] [Related]
12. Prolonging survival in vascularized bone allograft transplantation: developing specific immune unresponsiveness.
Paskert JP; Yaremchuk MJ; Randolph MA; Weiland AJ
J Reconstr Microsurg; 1987 Apr; 3(3):253-63. PubMed ID: 3298640
[TBL] [Abstract][Full Text] [Related]
13. [The role of TNF alpha in the allograft rejection of orthotopic rat liver transplantation].
Li Z; Liu Y; Feng Y
Zhonghua Yi Xue Za Zhi; 1997 Feb; 77(2):134-7. PubMed ID: 9596947
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
15. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
16. Results of vascularized joint allograft under immunosuppression with cyclosporine.
Muramatsu K; Doi K; Akino T; Shigetomi M; Kawai S
Microsurgery; 1993; 14(8):527-36. PubMed ID: 8271932
[TBL] [Abstract][Full Text] [Related]
17. Experimental vascularized bone allografting.
Randolph MA; Yaremchuk MJ; Moore JR; Robinson RA; Weiland AJ
Microsurgery; 1987; 8(4):210-7. PubMed ID: 3323772
[TBL] [Abstract][Full Text] [Related]
18. Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation.
Sekine Y; Bowen LK; Heidler KM; Van Rooijen N; Brown JW; Cummings OW; Wilkes DS
J Immunol; 1997 Oct; 159(8):4084-93. PubMed ID: 9378999
[TBL] [Abstract][Full Text] [Related]
19. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
[No Abstract] [Full Text] [Related]
20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
